PCCs Designed by Insilico's Generative AI Platform (IMAGE)

InSilico Medicine

PCCs Designed by Insilico's Generative AI Platform

Caption

The pan-TEAD inhibitor is one of a number of small molecules specially designed with novel structures using Insilico’s generative AI platform, Pharma.AI.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.